Blood biomarkers in cardioembolic stroke

Teresa García-Berrocoso, Israel Fernández-Cadenas, Pilar Delgado, Anna Rosell, Joan Montaner

    Research output: Contribution to journalArticleResearchpeer-review

    15 Citations (Scopus)


    One promising field in neurovascular diseases investigation is the use of biomarkers to guide stroke etiology diagnosis and classification. Since treatment differs among etiologic subtypes and nowadays many patients receive a diagnosis of undetermined stroke, biomarkers might become an important additional diagnostic tool. In this review we update current knowledge about biomarkers related with cardioembolic stroke etiology (such as BNP and D-dimer proteins, or PITX2 and ZFHX3 genes), that in the future, might allow rapidly guiding other diagnostic tests and accelerating the onset of an optimal secondary prevention. © 2010 Bentham Science Publishers Ltd.
    Original languageEnglish
    Pages (from-to)194-201
    JournalCurrent Cardiology Reviews
    Issue number3
    Publication statusPublished - 17 Sep 2010


    • Biomarker
    • Cardioembolic
    • Classification
    • Etiology
    • Natriuretic peptides
    • Stroke


    Dive into the research topics of 'Blood biomarkers in cardioembolic stroke'. Together they form a unique fingerprint.

    Cite this